Glutathione S-transferase C-terminal domain-containing protein (GSTCD) inhibitors encompass a diverse group of chemicals that interfere with the function of GSTCD. These inhibitors are primarily characterized by their ability to interact with the active site of the enzyme, either through covalent or non-covalent interactions, and thereby reduce its catalytic efficiency. The inhibition mechanisms vary among different classes of compounds, ranging from direct binding to the active site to indirect modulation of the protein's expression levels. Among these inhibitors, compounds like Ethacrynic acid and DL-Sulforaphane function through covalent modification of the active site cysteine residues, a critical component of the enzyme's catalytic mechanism. This modification leads to a permanent alteration in the protein structure and a consequent loss of enzymatic activity. Other inhibitors, such as Cibacron Blue 3GA and Chrysin, employ a non-covalent mode of inhibition. These compounds mimic the natural substrates of GSTCD or bind to its active site in a way that competitively prevents substrate access, thus inhibiting the enzyme's function.
Several natural phenolic compounds, including Ellagic Acid, Dihydrate, Curcumin, and Quercetin, are also effective inhibitors of GSTCD. These molecules typically exhibit their inhibitory effects by binding to the enzyme's active site and inducing conformational changes that reduce enzymatic activity. Additionally, β-Estradiol represents a unique case where the inhibition of GSTCD is achieved indirectly through the modulation of gene expression, highlighting the complexity of the interaction between small molecules and protein regulation. The significance of these inhibitors lies in their potential to modulate GSTCD activity, which can have broader implications in physiological processes where this enzyme plays a role. Understanding the diverse mechanisms through which these inhibitors function is crucial for exploring their potential applications in research contexts. The chemical diversity of GSTCD inhibitors underscores the enzyme's susceptibility to different types of molecular interactions, offering insights into its structural and functional properties.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ethacrynic acid | 58-54-8 | sc-257424 sc-257424A | 1 g 5 g | $90.00 $300.00 | 5 | |
Ethacrynic acid is a diuretic agent that also acts as an inhibitor of GSTCD by covalently modifying the active site cysteine residues in the protein. This modification disrupts the catalytic activity of GSTCD, leading to its inhibition. | ||||||
Cibacron Blue | 84166-13-2 | sc-507477 | 10 mg | $77.00 | ||
Cibacron Blue 3GA is a triazine dye known to inhibit GSTCD by binding non-covalently to its active site. This competitive inhibition results in the decrease of the protein's enzymatic activity. | ||||||
Ellagic Acid, Dihydrate | 476-66-4 | sc-202598 sc-202598A sc-202598B sc-202598C | 500 mg 5 g 25 g 100 g | $58.00 $95.00 $245.00 $727.00 | 8 | |
Ellagic Acid, Dihydrate, a natural phenolic compound, inhibits GSTCD by binding to its active site. This binding leads to a non-competitive inhibition where the compound interferes with the enzyme's activity without directly blocking substrate binding. | ||||||
Plumbagin | 481-42-5 | sc-253283 sc-253283A | 100 mg 250 mg | $52.00 $62.00 | 6 | |
Plumbagin is a naphthoquinone that inhibits GSTCD by interacting with its active site cysteine residues. This interaction leads to the modification of the protein and subsequent inhibition of its enzymatic function. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol, a natural estrogen, has been shown to inhibit GSTCD indirectly by modulating the expression levels of the protein, thereby influencing its activity in the cell. | ||||||
Chrysin | 480-40-0 | sc-204686 | 1 g | $38.00 | 13 | |
Chrysin, a flavonoid compound, exhibits inhibitory effects on GSTCD by binding to the active site of the enzyme, leading to a decrease in its catalytic efficiency. | ||||||
Vitamin K3 | 58-27-5 | sc-205990B sc-205990 sc-205990A sc-205990C sc-205990D | 5 g 10 g 25 g 100 g 500 g | $26.00 $36.00 $47.00 $136.00 $455.00 | 3 | |
Vitamin K3 inhibits GSTCD by interacting with its active site and modifying the protein structure, thereby reducing its enzymatic activity. | ||||||